tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VRTX Stock Latest News

Vertex Pharmaceuticals files automatic mixed securities shelf
The FlyVertex Pharmaceuticals files automatic mixed securities shelf
8d ago
VRTX
Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb
PremiumMarket News
Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb
9d ago
CRSP
MRNA
Vertex Pharmaceuticals: Strong Financial Performance and Promising Future Prospects Reinforce Buy Rating
PremiumRatings
Vertex Pharmaceuticals: Strong Financial Performance and Promising Future Prospects Reinforce Buy Rating
9d ago
VRTX
Cautious Outlook on Vertex Pharmaceuticals: Hold Rating Amid Growth Concerns and Premium Valuation
PremiumRatings
Cautious Outlook on Vertex Pharmaceuticals: Hold Rating Amid Growth Concerns and Premium Valuation
9d ago
VRTX
Vertex Pharmaceuticals upgraded to Hold from Sell at Canaccord yesterday
PremiumThe Fly
Vertex Pharmaceuticals upgraded to Hold from Sell at Canaccord yesterday
10d ago
VRTX
Vertex Pharmaceuticals Reports Strong Revenue Growth Amid Challenges
PremiumCompany AnnouncementsVertex Pharmaceuticals Reports Strong Revenue Growth Amid Challenges
10d ago
VRTX
Vertex Pharmaceuticals upgraded to Hold from Sell at Canaccord
Premium
The Fly
Vertex Pharmaceuticals upgraded to Hold from Sell at Canaccord
10d ago
VRTX
Coca-Cola reports Q4 beat, Elliott discloses Phillips 66 stake: Morning Buzz
Premium
The Fly
Coca-Cola reports Q4 beat, Elliott discloses Phillips 66 stake: Morning Buzz
11d ago
DB
DD
Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank
11d ago
VRTX
Vertex Pharmaceuticals price target raised to $520 from $460 at Truist
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $520 from $460 at Truist
11d ago
VRTX
Vertex Pharmaceuticals price target raised to $407 from $402 at RBC Capital
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $407 from $402 at RBC Capital
11d ago
VRTX
Vertex Pharmaceuticals’ Journavx: Strategic Market Adoption and Growth Outlook
PremiumRatings
Vertex Pharmaceuticals’ Journavx: Strategic Market Adoption and Growth Outlook
11d ago
VRTX
Vertex Pharmaceuticals price target raised to $459 from $450 at Morgan Stanley
PremiumThe FlyVertex Pharmaceuticals price target raised to $459 from $450 at Morgan Stanley
11d ago
VRTX
Vertex Pharmaceuticals: Mixed Financial Performance and Future Prospects Lead to Hold Rating
Premium
Ratings
Vertex Pharmaceuticals: Mixed Financial Performance and Future Prospects Lead to Hold Rating
11d ago
VRTX
Vertex Pharmaceuticals: Hold Rating Due to Mixed Outlook and Generic Competition Risks
Premium
Ratings
Vertex Pharmaceuticals: Hold Rating Due to Mixed Outlook and Generic Competition Risks
11d ago
VRTX
Vertex Pharmaceuticals price target raised to $467 from $435 at Barclays
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $467 from $435 at Barclays
11d ago
VRTX
Vertex Pharmaceuticals (VRTX) Sees Strong 2025 Revenue Growth
PremiumMarket News
Vertex Pharmaceuticals (VRTX) Sees Strong 2025 Revenue Growth
11d ago
VRTX
Positive Outlook for Vertex Pharmaceuticals: Strong Cystic Fibrosis Performance and Promising Product Launches Drive Buy Rating
PremiumRatings
Positive Outlook for Vertex Pharmaceuticals: Strong Cystic Fibrosis Performance and Promising Product Launches Drive Buy Rating
11d ago
VRTX
Vertex Pharmaceuticals Reports Strong 2024 Revenue Growth
PremiumCompany Announcements
Vertex Pharmaceuticals Reports Strong 2024 Revenue Growth
11d ago
VRTX
Closing Bell Movers: Lattice Semi up 13% on earnings
PremiumThe FlyClosing Bell Movers: Lattice Semi up 13% on earnings
11d ago
ACLS
ALAB
Vertex Pharmaceuticals Announces Key Leadership Changes
Premium
Company Announcements
Vertex Pharmaceuticals Announces Key Leadership Changes
11d ago
8K
VRTX
Vertex Pharmaceuticals reports Q4 EPS $3.98, consensus $4.02
Premium
The Fly
Vertex Pharmaceuticals reports Q4 EPS $3.98, consensus $4.02
11d ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >